Preliminary Clinical Data From Ongoing Phase 2 Study With Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors or Hematologic Malignancies

  1. Kindler, H.
  2. Harvey, R.D.
  3. Duska, L.R.
  4. Gandhi, L.
  5. Sullivan, R.J.
  6. Gastinne, T.
  7. Kwiatek, M.
  8. García-Sancho, A.M.
  9. Hadar, N.
  10. Kann, L.
  11. Faulhaber, N.
  12. Drescher, C.
Aldizkaria:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Argitalpen urtea: 2022

Alea: 174

Orrialdeak: S31-S32

Mota: Artikulua

DOI: 10.1016/S0959-8049(22)00884-X GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak